Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19.
Transfus Apher Sci
; 59(4): 102817, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: covidwho-1235989
ABSTRACT
Passive immunotherapy with plasma derived from patients convalescent from SARS-CoV-2 infection can be a promising approach in the treatment of COVID-19 patients. It is important that Blood Establishments are prepared to satisfy requests for immune plasma by defining the requirements applicable to plasma donors and the standards for preparation, qualification, storage, distribution and control of use of the product. This position paper is aimed to give recommendations on biological characteristics of a plasma preparation from convalescent donors and to support the evaluation of this therapeutic approach in more rigorous investigations.
Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Neumonía Viral
/
Inmunización Pasiva
/
Infecciones por Coronavirus
/
Betacoronavirus
Tipo de estudio:
Estudio experimental
/
Estudio pronóstico
Límite:
Humanos
Idioma:
Inglés
Revista:
Transfus Apher Sci
Asunto de la revista:
Hematología
Año:
2020
Tipo del documento:
Artículo
País de afiliación:
J.transci.2020.102817
Similares
MEDLINE
...
LILACS
LIS